Zurich – The healthcare start-up PIPRA is launching a Delirium Hub. The aim of the digital platform is to train medical staff in the prevention and treatment of post-operative delirium. The service is available in German and English.
PIPRA, a Zurich-based start-up founded in 2019, has launched a digital platform for the prevention and treatment of post-operative delirium. The core of the Delirium Hub is a scientifically based e-learning program aimed at healthcare professionals, according to a press release. The program is available in both English and German. In addition to learning courses, the program also includes online tools for delirium prevention and chat programs for exchanging information with other professionals.
Post-operative delirium is a disturbance of consciousness with deficits in perception and attention as well as other cognitive impairments that can occur a few hours or even days after an operation. Prevention and timely intervention can prevent life-threatening situations from arising.
"We want to make knowledge about delirium accessible to everyone. With the Delirium Hub, we offer a unique platform that helps healthcare professionals to better understand delirium in their daily practice and thus effectively prevent it," said Fabian Gautschi, Head of Product at PIPRA AG, in the press release. "The fact that our offering is now also available in German enables us to reach even more professionals and further improve the quality of patient care." ce/ww
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information